DYSPLASIX Trademark

Trademark Overview

On Wednesday, August 7, 2024, a trademark application was filed for DYSPLASIX with the United States Patent and Trademark Office. The USPTO has given the DYSPLASIX trademark a serial number of 98687204. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, August 7, 2024. This trademark is owned by Amplexd Therapeutics, Inc.. The DYSPLASIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaginal suppositories for treatment of cervical cancer and precursors to cervical cancer including high-risk human papillomaviruses; topical ointment for treatment of vulvar cancer and precursors to vulvar cancer including high-risk human papillomaviruses; topical ointment for treatment of penile cancer and precursors to penile cancer including high-risk human papillomaviruses; topical ointment, and oral rinse for head and neck cancers and precursors to head and neck cancer including high-risk human papillomaviruses; anal suppositories for treatment of anal cancer and precursors to anal cancer including high-risk human papillomaviruses.
dysplasix

General Information

Serial Number98687204
Word MarkDYSPLASIX
Filing DateWednesday, August 7, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaginal suppositories for treatment of cervical cancer and precursors to cervical cancer including high-risk human papillomaviruses; topical ointment for treatment of vulvar cancer and precursors to vulvar cancer including high-risk human papillomaviruses; topical ointment for treatment of penile cancer and precursors to penile cancer including high-risk human papillomaviruses; topical ointment, and oral rinse for head and neck cancers and precursors to head and neck cancer including high-risk human papillomaviruses; anal suppositories for treatment of anal cancer and precursors to anal cancer including high-risk human papillomaviruses.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmplexd Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Wednesday, August 7, 2024NEW APPLICATION ENTERED
Wednesday, August 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

dysplasix cancer high risk human including papillomaviruses precursors treatment ointment anal